Nintedanib
compare suppliers & send inquiries for free
Filters
Reset
Selected filters:
Type
Region
Qualifications
Country of origin
Follow us
Distributor
Valid Regulatory support
Marketing Intelligence to stay on trend and ahead in the market
Tailored value-added services that support the increase of market potential
+ 0
All certificates
Send inquiry
Replies quickly
Distributor
Fast Response and Good Communication
Willingness To Start From Small
Flexible Payment Terms
+ 0
All certificates
Send inquiry
Replies in a day or 2
How does it work?
You can register for free as long as you are registering on behalf of a legal company related to the pharmaceutical industry
Search in the search bar the product that you’re looking for. We’ll show you an overview of all available suppliers. Use the filters to select the relevant suppliers only
Have you found interesting suppliers? Then it’s time to contact them. Use the send inquiry button and send them a message. You can send for each product, 3 inquiries per week
Suppliers get notified by Pharmaoffer that they’ve received a new inquiry. They will come back to you with their questions, certificates, and offer in the chat on Pharmaoffer. We will send you an email in case of any news
Does the supplier meet your quality and commercial requirements? Then you can place the order. Just follow the steps of our order module
Producer
+ 0
All certificates
Send inquiry
Replies slower than most
Send inquiry
Not active
Producer
+ 0
All certificates
Send inquiry
Not active
Send inquiry
Not active
Send inquiry
Not active
Send inquiry
Not active
Looking for Nintedanib 656247-17-5?
- API | Excipient name:
- Nintedanib
- Synonyms:
- Nintedanib esylate
- Cas Number:
- 656247-17-5
- DrugBank number:
- DB09079
- Unique Ingredient Identifier:
- G6HRD2P839
About Nintedanib
Why are people looking for Nintedanib? Nintedanib is a small molecule kinase inhibitor used in the treatment of pulmonary fibrosis, systemic sclerosis-associated interstitial lung disease, and non-small cell lung cancer (NSCLC) It was first approved for use in the United States in 2014. Within the spectrum of idiopathic pulmonary fibrosis treatment options, nintedanib is currently one of only two disease-modifying therapies available and indicated for the condition (the other being Pirfenidone) and as such is used as a first-line treatment following diagnosis to slow down the progressive loss of lung function. As a chemotherapeutic agent for NSCLC, nintedanib, in combination with Docetaxel, is reserved for patients who have tried and failed first-line chemotherapeutic options.
Do you want to buy this product? Send an inquiry to the listed suppliers that meets your quality requirements.
Nintedanib manufacturers | traders | suppliers
We have 8 companies offering Nintedanib from 5 different countries.
Get in contact with the supplier of your choice:
- DKSH from Switzerland
- Shandong Octagon Chemicals Limited from China
- Formosa Labs from Taiwan
- Cipla from India
- Glenmark Pharma from India
- Sun Pharma from India
- MSN Labs. from India
- Olon from Italy
Let the supplier know whether you are looking for a product with a specific monograph such as EP (Ph. Eur.), USP, JP, BP or another quality. Or, whether you are looking for hydrochloride (HCl), anhydricum, base, micronisatum or a specific purity.
You can use the filters to find high-quality suppliers. For example, you can select GMP, FDA or ISO certified suppliers. Visit our FAQ page or use the chat box in the corner to get more information about Pharmaoffer.
